BENJAMIN HAALAND portrait
  • Associate Professor, Population Health Sciences
  • Co-Director, Cancer Biostatistics Shared Resource, Huntsman Cancer Institute
  • Adjunct Associate Professor, Population Health Sciences
801-213-3485

Research Summary

Benjamin Haaland, PhD, is Co-Director of the Cancer Biostatistics Shared Resource at Huntsman Cancer Institute and an Associate Professor in the Department of Population Health Sciences. Dr. Haaland has substantial expertise in design and analysis of randomized controlled trials, evidence synthesis and meta-analysis, non-parametric modeling of longitudinal and multi-level data, and applications of modern machine learning techniques to predictive health, with a major emphasis on cancer.

Education

  • BS, Applied Mathematics, Montana State University, Bozeman
  • MS, Statistics, Montana State University, Bozeman
  • PhD, Statistics, University of Wisconsin-Madison

Biography

Ben Haaland is an Associate Professor in the Department of Population Health Sciences. From 2010-2014, Ben Haaland was an assistant professor in the Centre for Quantitative Medicine at Duke-NUS Graduate Medical School, Singapore and from 2014-2017, Ben was an assistant professor in the School of Industrial and Systems Engineering at Georgia Institute of Technology. Ben joined the University of Utah in 2017, and was appointed Co-Director of the Cancer Biostatistics Shared Resource in 2018.

Selected Recent Publications

Aguiar PN Jr, Haaland B, Park W, San Tan P, Del Giglio A, de Lima Lopes G Jr (2018). Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer. JAMA Oncol, 4(8), 1080-1084.

Georgieva M, da Silveira Nogueira Lima JP, Aguiar P Jr, de Lima Lopes G Jr, Haaland B (2018). Cost-effectiveness of pembrolizumab as first-line therapy for advanced non-small cell lung cancer. Lung Cancer, 124, 248-254.

Swami U, Nussenzveig RH, Haaland B, Agarwal N (2019). Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvement. Ann Transl Med.

Hale P, Hahn AW, Rathi N, Pal SK, Haaland B, Agarwal N (2019). Treatment of metastatic renal cell carcinoma in older patients: A network meta-analysis. J Geriatr Oncol, 10(1), 149-154.

Martin C, Haaland B, Tward AE, Dechet C, Lowrance W, Stephenson RA, Hanson H, O'Neil B (2019). Describing the Spectrum of Patient Reported Outcomes after Radical Prostatectomy: Providing Information to Improve Patient Counseling and Shared Decision Making. LID - 10.1016/j.juro.2018.10.014 [doi]. (Epub ahead of print) J Urol.

Hahn AW, Esther J, Haaland B, Swami U, Dizman N, Rathi N, Maughan BL, Pal SK, Agarwal N. (2019). Patterns of treatment in metastatic renal cell carcinoma for older versus younger patients. (Epub ahead of print) Journal of Geriatric Oncology.

Wu YP, Parsons BG, Nagelhout E, Haaland B, Jensen J, Zaugg K, Caputo H, Lensink R, Harding G, Yancey J, Klein SZ. (2019) A four-group experiment to improve Western high school students’ sun protection behaviors. Translational behavioral medicine, 9(3), 468-479.

Sung CL, Wang W, Plumlee M, Haaland B. (2019) Multiresolution Functional ANOVA for Large-Scale, Many-Input Computer Experiments. Journal of the American Statistical Association, 1-23.